Skip to main content
. 2018 Apr 12;36(7):809–822. doi: 10.1007/s40273-018-0641-6

Fig. 1.

Fig. 1

Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram detailing the search for records pertaining to economic data for hepatic encephalopathy, and administration of rifaximin and/or lactulose. Search terms included hepatic encephalopathy, economic, health-related quality of life, cost, cost utility, cost effectiveness, rifaximin, lactulose adherence, and patient-reported outcomes. HE hepatic encephalopathy